Medical Oncology

Doç. Dr. Seher Nazlı Kazaz

Doctor and researcher Medical Park Karadeniz Trabzon
NeoplasmsCarcinoma, Transitional CellMeningiomaMeningeal NeoplasmsAdenocarcinoma
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Neoplasms 2 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Carcinoma, Transitional Cell 2 publications
  • Meningioma 2 publications
  • Meningeal Neoplasms 2 publications
  • Adenocarcinoma 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: medicalpark.com.tr.

  • Akciğer kanseri
  • Meme kanseri
  • Jinekolojik kanserler
  • Ürogenital kanserler
  • Kolorektal kanserler
  • Kemoterapi

CV

Education and experience

From source

Education

  • 1997-2005Karadeniz Teknik Üniversitesi- Tıp Eğitimimedicalpark.com.tr
  • 2007-2012Karadeniz Teknik Üniversitesi Tıp Fakültesi İç Hastalıkları AbD- İç Hastalıkları- Doktora/S.Yeterlik/ Tıpta Uzmanlıkmedicalpark.com.tr
  • 2013-2017Dokuz Eylül Üniversitesi Tıp Fakültesi İç Hastalıkları AbD Tıbbi Onkoloji Bilim Dalı- Tıbbi Onkoloji- Yandal Uzmanlıkmedicalpark.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologymedicalpark.com.trFrom source
  • Department name at the sourceMedikal Onkoloji (Tıbbi Onkoloji)medicalpark.com.trFrom source
  • InstitutionMedical Park Karadenizmedicalpark.com.trFrom source
  • Area of workNeoplasmsExtracted from 2 publications · Model version —From source
  • Publications49 publicationsOpenAlex, Europe PMC, ORCIDFrom source
  • ORCID0000-0002-8181-000XORCIDFrom source
  • Last synchronised4 November 2026 20:34https://www.medicalpark.com.tr/hekimler/seher-nazli-kazazmedicalpark.com.tr

Scientific work

Publications on Neoplasms

49 publications

  1. Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma

    Immunotherapy, 2026

    DOI 10.1080/1750743x.2026.2722548 PMID 42683510 Open-access full textSource: OpenAlex

  2. Spontaneous Bladder Rupture After Radiotherapy

    Bulletin of Urooncology, 2026

    DOI 10.4274/uob.galenos.2025.2025.4.1 Open-access full textSource: OpenAlex

  3. Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program

    Future Oncology, 2025

    DOI 10.1080/14796694.2025.2570637 PMID 41103123 Open-access full textSource: OpenAlex

  4. Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program (EAP).

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.5_suppl.708 1 citation (OpenAlex) Source: OpenAlex

  5. Güncel Üroloji Çalışmaları VI - Prostat Hastalıkları

    Akademisyen Kitabevi eBooks, 2025

    DOI 10.37609/akya.3445 Open-access full textSource: OpenAlex

  6. Compliance with hepatocellular carcinoma screening and the effectiveness of screening in cirrhotic patients

    DergiPark (Istanbul University), 2025

    Open-access full textSource: OpenAlex

  7. Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2403051 PMID 39257075 2 citations (Europe PMC) Source: OpenAlex

  8. Pathological complete response and associated factors in breast cancer after neoadjuvant chemotherapy: A retrospective study

    Turkish journal of surgery, 2024

    DOI 10.47717/turkjsurg.2024.6308 PMID 39036007 4 citations (Europe PMC) Open-access full textSource: Europe PMC

  9. Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry

    Turkish journal of medical sciences, 2024

    DOI 10.55730/1300-0144.5843 PMID 39295608 3 citations (Europe PMC) Open-access full textSource: Europe PMC

  10. The Effect of Metformin on Survival in Patients with Non-Small Cell Lung Cancer

    Sağlık Bilimlerinde Değer, 2024

    DOI 10.33631/sabd.1216847 Open-access full textSource: ORCID

View all 49 publications